IN HYPOPHOSPHATASIA (HPP), DEFICIENT ALP can ruin bones, bodies, and lives. Alexion Endocrinology, Diabetes & Metabolism Case Reports

ISSN 1470-3947 (print)
ISSN 1479-6848 (online)

Searchable abstracts of presentations at key conferences in endocrinology

Published by BioScientifica
Endocrine Abstracts (2012) 29 P247 

Sporadic pseudohypoparathyroidism with osteitis fibrosa cystica

L. Cianferotti1, A. Biagini1, E. Fernández-Rebollo2, H. Jüppner2 & C. Marcocci1

Author affiliations

Pseudohypoparathyroidism (PHP) refers to a group of heterogeneous genetic diseases, characterized by resistance to PTH and frequently other hormones activating cAMP-dependent events down-stream of different G protein-coupled receptors. PHP-Ia and Ib, the most frequent forms, are caused by mutations within the GNAS locus that encodes Gαs and several splice variants thereof. We describe a 36-year-old man with sporadic PHP-Ib with renal PTH-resistance, yet severe hyperparathyroid bone disease. The patient presented at age 8 years with limping due to bone deformities, who was treated with multiple osteotomies. Biochemical evaluation showed hypocalcemia (7.5 mg/dl) with high PTH (504 pg/ml) and increased ALP (487 IU/l). After restoring serum calcium to the low-normal range by oral calcium (1 g/day) and calcitriol (0.5–1 μg/day), PTH and ALP progressively increased (2100 pg/ml and 980 IU/l, respectively). Cortical bone mineral density (BMD) was markedly reduced (distal radius T-score: −7.7). Subperiosteal bone resorption with acroosteolysis, salt-and-pepper appearance of the skull, bone cysts and long bone deformities were observed radiographically. Parathyroid ultrasound showed four-gland hyperplasia. Epigenetic analyses of GNAS locus documented loss of methylation at all four DMRs without evidence for patUPD20q; the 3-kb STX16 deletion was excluded. No features of PHP-Ib were present in first-degree relatives. After increasing calcitriol to 4 μg/day, a progressive fall of PTH and ALP occurred over the course of 8 months (130 pg/ml and 97 U/L, respectively), while serum calcium remained within normal limits without evidence for hypercalciuria. Cortical BMD markedly increased (+6.5%) and bone pain vanished. Nine months later hypercalcemia developed, likely because of completion of the remineralization process. Calcitriol was reduced to 1.5 μg/day and normocalcemia was restored. This is an unusual case of sporadic PHP-Ib with marked bone involvement, in whom the standard dose of calcitriol was insufficient. Despite long-standing disease, PTH levels declined dramatically and approached the normal range.

Declaration of interest: The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research project.

Funding: This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

This Issue/Conference

Article tools

My recently viewed abstracts

My recent searches